semaglutide va criteria for use Subcutaneous weekly with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial The multifaceted effects of semaglutide:

Researchers seeking the authorized drug for any clinical purpose should consult a licensed Canadian prescriber

PMID: 30429357

Patients with a history of pancreatitis should use caution, and those with severe gastrointestinal disease (such as gastroparesis) may not tolerate the medication well due to its effects on gastric emptying

In clinical trials: Semaglutide: Approximately 7% discontinued due to adverse events Tirzepatide: Approximately 4-7% discontinued due to adverse events (dose dependent) Retatrutide: Approximately 6-10% discontinued due to adverse events (dose dependent) These rates are relatively close, suggesting that despite the differences in mechanism and side effect profiles, all three medications are tolerable for the vast majority of people who start them

14 How Do I Take Liraglutide or Semaglutide